CCDHB Logo

Chimerism analysis

Chimerism Analysis


Wellington Regional Genetics Laboratory (WRGL) is very pleased to now offer chimerism testing for the detection of minimum residual disease (MRD) in patients following allogenic haematopoietic transplantation.  
 

Background

Thousands of people suffer from leukaemia, aplastic anaemia and immune deficiency diseases in which the stem cells of bone marrow malfunction, causing defective blood cells that interfere with normal blood production and may invade other tissues. Treatments to destroy abnormal stem cells followed by transplantation of stem cells from compatible, healthy donor tissue have increased the success of treating these diseases. A chimera, an individual composed of two genetically distinct types of cells, results from the transplant.
Quantification of chimerism is used to monitor engraftment of donor cells following stem cell transplantation and is essential for early diagnosis of graft failure or relapse of the disease.

 

Chimerism Testing at WRGL

Analysis of transplant recipient, donor and post-transplant samples using PCR of a panel of polymorphic microsatellite markers followed by data analysis using ChimerMarker software from SoftGenetics is performed. The software indentifies markers which can be used to track the recipient’s response to bone marrow transplant and the percentage donor chimerism for each post transplant sample received is reported.

 

Cost, Sample Requirements & Turnaround Times

 

Test

Cost NZD*

Sample Requirements

Current TAT

Chimerism analysis -
work-up & first post transplant sample
 
$350 3 ml of whole blood in EDTA (purple Top) from recipient pre-transplant
3 ml of whole blood in EDTA (purple Top) from donor
1 week from receipt of each post-transplant sample
Chimerism analysis -
subsequent post transplant sample
$200 3 ml of whole blood in EDTA (purple Top) from recipient post-transplant
1 week from receipt of each post-transplant sample

 
*No direct charge for the central region DHBs covered by the Crown Funding Agreement
 

Reference


Bryant E, Martin PJ. Documentation of engraftment and characterization of chimerism following hematopoietic cell transplantation. In: Forman S, Blune K, Thomas ED, eds. Hematopoietic cell transplantation. 2nd ed. Malden, MA: Blackwell Science, 1998.


If you require any additional information about this test or any other aspect of our service, please do not hesitate to contact us.

Clive Felix
Service Leader
clive.felix@ccdhb.org.nz

Chimerism Analysis


Wellington Regional Genetics Laboratory (WRGL) is very pleased to now offer chimerism testing for the detection of minimum residual disease (MRD) in patients following allogenic haematopoietic transplantation.  
 

Background

Thousands of people suffer from leukaemia, aplastic anaemia and immune deficiency diseases in which the stem cells of bone marrow malfunction, causing defective blood cells that interfere with normal blood production and may invade other tissues. Treatments to destroy abnormal stem cells followed by transplantation of stem cells from compatible, healthy donor tissue have increased the success of treating these diseases. A chimera, an individual composed of two genetically distinct types of cells, results from the transplant.
Quantification of chimerism is used to monitor engraftment of donor cells following stem cell transplantation and is essential for early diagnosis of graft failure or relapse of the disease.

 

Chimerism Testing at WRGL

Analysis of transplant recipient, donor and post-transplant samples using PCR of a panel of polymorphic microsatellite markers followed by data analysis using ChimerMarker software from SoftGenetics is performed. The software indentifies markers which can be used to track the recipient’s response to bone marrow transplant and the percentage donor chimerism for each post transplant sample received is reported.

 

Cost, Sample Requirements & Turnaround Times

 

Test

Cost NZD*

Sample Requirements

Current TAT

Chimerism analysis -
work-up & first post transplant sample
 
$350 3 ml of whole blood in EDTA (purple Top) from recipient pre-transplant
3 ml of whole blood in EDTA (purple Top) from donor
1 week from receipt of each post-transplant sample
Chimerism analysis -
subsequent post transplant sample
$200 3 ml of whole blood in EDTA (purple Top) from recipient post-transplant
1 week from receipt of each post-transplant sample

 
*No direct charge for the central region DHBs covered by the Crown Funding Agreement
 

Reference


Bryant E, Martin PJ. Documentation of engraftment and characterization of chimerism following hematopoietic cell transplantation. In: Forman S, Blune K, Thomas ED, eds. Hematopoietic cell transplantation. 2nd ed. Malden, MA: Blackwell Science, 1998.


If you require any additional information about this test or any other aspect of our service, please do not hesitate to contact us.

Clive Felix
Service Leader
clive.felix@ccdhb.org.nz

ABOUT US

Wellington Regional Genetics Laboratory (WRGL) provides a comprehensive, integrated diagnostic cytogenetic and molecular genetic testing service

btn find
 
f1
 

CONTACT US

(04) 918-5352
wrgl@ccdhb.org.nz